Human brain changes after first psilocybin use.
Saved in:
| Title: | Human brain changes after first psilocybin use. |
|---|---|
| Authors: | Lyons T; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Spriggs M; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Kerkelä L; UCL Great Ormond Street Institute of Child Health, University College London, London, UK., Rosas FE; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.; Department of Informatics, University of Sussex, Brighton, UK.; Data Science Institute, Imperial College London, London, UK.; Centre for Complexity Science, Imperial College London, London, UK.; Centre for Eudaimonia and Human Flourishing, University of Oxford, Oxford, UK., Roseman L; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Mediano PAM; Centre for Complexity Science, Imperial College London, London, UK.; Department of Psychology, University of Cambridge, Cambridge, UK.; Department of Psychology, Queen Mary University of London, London, UK., Timmermann C; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Oestreich L; School of Psychology and Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland, Brisbane, QLD, Australia., Pagni BA; NYU Langone Center for Psychedelic Medicine, Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA., Zeifman RJ; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.; NYU Langone Center for Psychedelic Medicine, Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.; Department of Psychology, The New School for Social Research, New York, NY, USA., Hampshire A; Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Trender W; Department of Brain Sciences, Imperial College London, London, UK., Douglass HM; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Girn M; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.; Carhart-Harris Lab, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Godfrey K; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Kettner H; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK.; Carhart-Harris Lab, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Sharif F; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Espasiano L; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Gazzaley A; Neuroscape, Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Wall MB; Invicro London, Hammersmith Hospital, Faculty of Medicine, Imperial College London, London, UK., Erritzoe D; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Nutt DJ; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK., Carhart-Harris RL; Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, UK. robin.carhart-harris@ucsf.edu.; Carhart-Harris Lab, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. robin.carhart-harris@ucsf.edu. |
| Source: | Nature communications [Nat Commun] 2026 May 05; Vol. 17 (1). Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-026-71962-3 |
